BCI
WGS icon

Brinker Capital Investments’s GeneDx Holdings WGS Stock Holding History

Brinker Capital Investments’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,630
Closed -$992K – 2269
2025
Q4 		$992K Sell
7,630
-164
-2% -$22.5K 0.01% 1231
2025
Q3 		$840K Buy
+7,794
New +$849K 0.01% 1310

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Brinker Capital Investments's WGS Position: Q1 2026 in Review

Brinker Capital Investments sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 7,630 shares — an estimated $992K sold.

Brinker Capital Investments first reported a position in WGS in Q3 2025 and held it in 2 quarters. The position peaked at $992K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Brinker Capital Investments reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Brinker Capital Investments sold 7,630 GeneDx Holdings shares in Q1 2026, an estimated $992K.
  • Brinker Capital Investments first reported a position in GeneDx Holdings in Q3 2025 and held it in 2 quarters.
  • Brinker Capital Investments's GeneDx Holdings position peaked at $992K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.